Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Stock Jumps 8.8% – Should You Buy?

Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF – Get Free Report) traded up 8.8% during trading on Wednesday. The company traded as high as $28.09 and last traded at $28.09. Approximately 294 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 3,061 shares. The stock had previously closed at $25.8150.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on FSPKF shares. Citigroup upgraded shares of Fisher & Paykel Healthcare to a “buy” rating in a report on Thursday, September 10th. Royal Bank Of Canada upgraded shares of Fisher & Paykel Healthcare from a “sector perform” rating to an “outperform” rating in a research note on Tuesday, September 15th. Two investment analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, the company has a consensus rating of “Buy”.

Get Our Latest Stock Report on Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Trading Up 8.8%

The firm has a fifty day simple moving average of $25.85 and a 200 day simple moving average of $23.61.

About Fisher & Paykel Healthcare

(Get Free Report)

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that develops, manufactures and markets products used in respiratory care, acute care and the treatment of obstructive sleep apnea. Its technologies are designed to support breathing, improve patient comfort and help healthcare professionals deliver respiratory therapies in hospitals, clinics and the home.

The company’s product portfolio includes respiratory humidification systems, heated breathing circuits, nasal high-flow therapy products, anesthesia and operating-room equipment, neonatal respiratory care products, and masks and related systems for sleep apnea treatment.

Featured Articles

Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.